These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7053457)

  • 1. Rubella antibody persistence after immunization.
    Herrmann KL; Halstead SB; Wiebenga NH
    JAMA; 1982 Jan; 247(2):193-6. PubMed ID: 7053457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella immunization. Persistence of antibody four years after a large-scale field trial.
    Herrmann KL; Halstead SB; Brandling-Bennett AD; Witte JJ; Wiebenga NH; Eddins DL
    JAMA; 1976 May; 235(20):2201-4. PubMed ID: 946844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands.
    Chu SY; Bernier RH; Stewart JA; Herrmann KL; Greenspan JR; Henderson AK; Liang AP
    JAMA; 1988 Jun; 259(21):3133-6. PubMed ID: 3367488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological response to rubella revaccination.
    Serdula MK; Halstead SB; Wiebenga NH; Herrmann KL
    JAMA; 1984 Apr; 251(15):1974-7. PubMed ID: 6700099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rubella-vaccinated students. Follow-up in a public school system.
    Schiff GM; Rauh JL; Young B; Trimble S; Rotte T; Schiff BE
    JAMA; 1978 Dec; 240(24):2635-7. PubMed ID: 712979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further evaluation of the optimum age for rubella vaccine administration.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1979 Dec; 133(12):1237-9. PubMed ID: 517472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late seroconversion following HPV-77, DE5 rubella virus vaccine.
    Wilkins J
    Am J Obstet Gynecol; 1975 Apr; 121(7):998-1002. PubMed ID: 1115189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to intranasal challenge with Rubella virus two years after vaccination: comparison of three vaccines.
    Grillner L
    J Infect Dis; 1976 Jun; 133(6):637-41. PubMed ID: 932491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on live rubella vaccine. VI. Seroepidemiological surveillance and immunization of adolescents in high school.
    Minekawa Y; Takahashi M; Ueda S; Ogino T
    Biken J; 1975 Sep; 18(3):149-54. PubMed ID: 1191245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-three-year follow-up study of rubella antibodies after immunization in a closed population, and serological response to revaccination.
    Asahi T; Ueda K; Hidaka Y; Miyazaki C; Tanaka Y; Nishima S
    Vaccine; 1997 Nov; 15(16):1791-5. PubMed ID: 9364685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing antibodies after rubella vaccination of newly delivered women: a comparison between three vaccines.
    Grillner L
    Scand J Infect Dis; 1975; 7(3):169-72. PubMed ID: 1237176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success and failure of a rubella immunization programme.
    Swartz TA; Porath EB; Hornstein L
    Dev Biol Stand; 1979; 43():355-60. PubMed ID: 520682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trials with a live attenuated rubella virus vaccine, Cendehill strain.
    Grant L; Belle EA; Provan G; King SD; Sigel MM
    J Hyg (Lond); 1970 Sep; 68(3):505-10. PubMed ID: 5272349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling rubella: problems and perspectives.
    Horstmann DM
    Ann Intern Med; 1975 Sep; 83(3):412-7. PubMed ID: 1180441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal versus subcutaneous rubella vaccination in schoolgirls.
    Midulla M; Assensio AM; Balducci L; Vanni O; Msstropasqua S
    Dev Biol Stand; 1976; 33():241-8. PubMed ID: 955270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and immunization of rubella-susceptible women. Experience in a large, prepaid medical group.
    Shlian DM
    JAMA; 1978 Aug; 240(7):662-3. PubMed ID: 671687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
    Hillary IB; Freestone DS
    J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.